Explanatory note
United Kingdom
(This note is not part of the Order)
This Order applies sections 731, 733 and 734 of the Income Tax (Trading and Other Income) Act 2005 (c.5) (periodical payments of personal injury damages etc.) to certain periodical payments to persons infected by hepatitis C through contaminated blood or blood products used by the NHS. The effect of the Order is that no liability to income tax will arise for the recipients of those payments.
Article 1 defines Skipton Fund Limited and Qualifying Person. Skipton Fund Limited is a company which has been set up to administer payments funded by the Department of Health to Qualifying Persons. A Qualifying Person is defined by reference to the agreement entered into between the Secretary of State for Health and Skipton Fund Limited dated 24 March 2011. A copy of the agreement may be obtained by writing to the registered office of the company. The address is Skipton Fund Limited c/o Ward Williams Business Advisers Limited, Bay Lodge, 36 Harefield Road, Uxbridge, Middlesex, UB8 1PH.
Article 2 applies sections 731, 732 and 734 to payments made to a Qualifying Person pursuant to a scheme or arrangement administered by Skipton Fund Limited, subject to modifications specified in the article.
A Tax Information and Impact Note covering this instrument will be published on the HMRC website athttp://www.hmrc.gov.uk/thelibrary/tiins.htm